You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial
|
|---|---|
| Published in |
Arthritis Research & Therapy, October 2014
|
| DOI | 10.1186/s13075-014-0451-y |
| Pubmed ID | |
| Authors |
Juan V Luciano, Francesco D’Amico, Marta Cerdà-Lafont, María T Peñarrubia-María, Martin Knapp, Antonio I Cuesta-Vargas, Antoni Serrano-Blanco, Javier García-Campayo |
| Abstract |
Cognitive behavioral therapy (CBT) and U.S. Food and Drug Administration (FDA)-recommended pharmacologic treatments (RPTs; pregabalin, duloxetine, and milnacipran) are effective treatment options for fibromyalgia (FM) syndrome and are currently recommended by clinical guidelines. We compared the cost-utility from the healthcare and societal perspectives of CBT versus RPT (combination of pregabalin + duloxetine) and usual care (TAU) groups in the treatment of FM. |
X Demographics
The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 18% |
| United States | 3 | 18% |
| Japan | 2 | 12% |
| United Kingdom | 1 | 6% |
| Canada | 1 | 6% |
| Brazil | 1 | 6% |
| Unknown | 6 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 14 | 82% |
| Scientists | 2 | 12% |
| Practitioners (doctors, other healthcare professionals) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 205 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 202 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 28 | 14% |
| Student > Master | 25 | 12% |
| Student > Bachelor | 25 | 12% |
| Student > Ph. D. Student | 13 | 6% |
| Other | 13 | 6% |
| Other | 48 | 23% |
| Unknown | 53 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 41 | 20% |
| Psychology | 33 | 16% |
| Nursing and Health Professions | 29 | 14% |
| Agricultural and Biological Sciences | 7 | 3% |
| Economics, Econometrics and Finance | 7 | 3% |
| Other | 30 | 15% |
| Unknown | 58 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2021.
All research outputs
#2,492,170
of 24,654,957 outputs
Outputs from Arthritis Research & Therapy
#489
of 3,148 outputs
Outputs of similar age
#27,409
of 258,878 outputs
Outputs of similar age from Arthritis Research & Therapy
#4
of 46 outputs
Altmetric has tracked 24,654,957 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,148 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 258,878 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.